Document: NUREG-0800
Document ID: 8ff38c60-7fce-45a8-a63c-c75b32b18056
Document Type: srp
Title: LIQUID WASTE MANAGEMENT SYSTEM
Source: NUREG-0800
Source URL: https://www.nrc.gov/docs/ML0520/ML052070608.pdf
Revision Date: 2023-06
Chapter: 11
Section ID: 11.2
CFR Part: 
CFR Title: 

Content:
erion 61 (GDC 61) as it relates to radioactive liquid waste 27 management systems to being designed to assure ensure adequate safety under normal 28 29 and postulated accident conditions. The relevant requirements of the Commission regulations identified above are met by using the regulatory positions contained in the following regulatory guides listed below: a. Regulatory Guide 1.110 as it relates to performing a cost-benefit analysis for reducing cumulative dose to the population by using available technology. b. Regulatory Guide 1.143 as it relates to the seismic design and quality group classification of components used in the liquid waste treatment management system and structures housing the systems and the provisions used to control 30 leakages. 5. 10 CFR Part 50, Appendix I, Sections II.A and II.D as it relates to the numerical guides for dose design objectives and limiting conditions for operation to meet the "as low as is reasonably achievable" criterion. The liquid radwaste treatment management system should have the capability to meet the requirements specified in 10 CFR Part 20, §20.106 § 20.1302, and 10 CFR Part 50, § 50.34a, 31 and General Design Criteria 60 and 61 of Appendix A of 10 CFR Part 50 and the dose design objectives specified in Sections II.A and II.D of Appendix I to 10 CFR Part 50, including provisions to treat liquid radioactive waste. 1. Specific criteria necessary to meet the relevant requirements of the Commission regulations are as follows: 11.2-5 DRAFT Rev. 3 - April 1996 a. The calculated annual total quantity of all radioactive material released from each reactor at the site to unrestricted areas will not result in an estimated annual dose or dose commitment from liquid effluents for any individual in an unrestricted area from all pathways of exposure in excess of 3 millirems0.03 mSv (3 mrem)32 to the total body or 10 millirems0.1 mSv (10 mrem) to any organ. 33 b. In addition to 1.a above, the liquid radwaste treatment